Intra-Trac® Oral BbPi

Our proprietary formulation and patented
Immuno-Mist-R™ technology make it possible.

icon: canine

Product Description

Bordetella bronchiseptica (avirulent live culture), canine parainfluenza virus (modified live virus)

Two of the most common respiratory pathogens vaccinated against are Bordetella bronchiseptica (Bb) and canine parainfluenza virus (Pi). However, an oral combination Bb and Pi vaccine has never been possible—until now.

Vaccinate with a new level of confidence and ease:

  • Groundbreaking Immuno-Mist-R™ technology dramatically increases mucosal surface area contact
  • Provides rapid onset of protection within 72 hours for B. bronchiseptica
  • Broad mucosal coverage induces an effective immune response
  • Oral administration offers comfort for dogs and convenience for staff

Twist, mist, and go!

The first-of-its-kind Immuno-Mist-R™ applicator delivers the vaccine in a fine mist for greater mucosal coverage than traditional oral vaccines.

Vaccinate against Bb and Pi, together, in 3 easy steps.*

Step 1

Draw vaccine into Luer-lock
syringe and remove the needle.

*Refer to product insert for complete instructions.

Step 2

Twist on Immuno-Mist-R™
applicator until tight.

Step 3

Mist toward the back of the mouth
for can’t-miss coverage.

How to administer

  • 1-mL dose reconstituted prior to administration
  • To be administered orally
  • Luer-lock syringe & patented Immuno-Mist-R™ applicator included
  • Approved for dogs 7 weeks of age or older

How it works

  • Patented Immuno-Mist-R™ provides broad mucous membrane surface coverage
  • Stimulates an effective antibody response
  • Mucosal antibodies attack the pathogens before they enter the body

Efficacy

SHORTEN THE DURATION OF COUGHING IN YOUR PATIENTS1

icon: plus icon: minus

5X SHORTER DURATION OF COUGHING RELATED TO B. BRONCHISEPTICA COMPARED TO CONTROLS1

  • 21 dogs were given a 1-mL dose of Nobivac® Intra-Trac® Oral BbPi orally at Day 0
  • 21 dogs were given placebo orally at Day 0
  • Dogs were challenged 5 weeks post vaccination

PROTECT DOGS WITH SHORT SHEDDING PERIOD1

icon: plus icon: minus

NOBIVAC® INTRA-TRAC®3 INTRANASAL OFFERS ADVANTAGES OVER ORAL AND INJECTABLE VACCINES

4x shorter duration of shedding related to CPiV compared to controls1

Significantly reduced long-term bacterial shedding compared to controls1

  • 20 dogs were given 1-mL dose of Nobivac® Intra-Trac® Oral BbPi
  • orally at Day 0
  • 19 dogs were given placebo orally at Day 0
  • Dogs were challenged 3 weeks post vaccination
  • 21 dogs were given 1-mL dose of Nobivac® Intra-Trac® Oral BbPi
  • orally at Day 0
  • 21 dogs were given placebo orally at Day 0
  • Dogs were challenged 5 weeks post vaccination (Day 36)

Resources

Digital Detailer

Nobivac® Intra-Trac® Oral BbPi

Download the full digital detailer for an interactive look at this revolutionary vaccine.